InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Dagnon Terry. Director active across 1 companies, notably Outlook Therapeutics, Inc.. Cumulatively, 5 filings have been recorded. Total volume traded: €97k. The latest transaction was filed on 21 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
€9,96910,000 shares@ €0.99690.036% mcap10.3% of flow
Common Stock
SEC:0001209191-22-038989:0·
Ideal exit: 18 Mar 2023 (T+270)
€30,76325,201 shares@ €1.22070.11% mcap71.0% of flow
Common Stock
SEC:0001209191-21-068135·
Ideal exit: 2 Sept 2022 (T+270)
€30,76325,201 shares@ €1.22070.11% mcap31.8% of flow
Common Stock
SEC:0001209191-21-068135:0·
Ideal exit: 2 Sept 2022 (T+270)
€12,55910,000 shares@ €1.25590.046% mcap29.0% of flow
Common Stock
SEC:0001209191-21-067838·
Ideal exit: 30 Aug 2022 (T+270)
€12,55910,000 shares@ €1.25590.046% mcap13.0% of flow
Common Stock
SEC:0001209191-21-067838:0·
Ideal exit: 30 Aug 2022 (T+270)
5 of 5 declarations
About Dagnon Terry
Terry Dagnon is a director at Outlook Therapeutics, Inc.
